周邊動脈疾病市場規模、佔有率及成長分析（按類型、治療方法、疾病、給藥途徑、最終用戶和地區）—產業預測，2025 年至 2032 年

預計 2023 年周邊動脈疾病市場規模將達到 53 億美元，從 2024 年的 58.5 億美元成長到 2032 年的 129.1 億美元，預測期內（2025-2032 年）的複合年成長率為 10.4%。

截至 2023 年 10 月，約有 650 萬 40 歲及以上的美國人患有周邊動脈疾病(PAD)，市場調查顯示，非裔美國人的盛行率更高。老化社會是周邊動脈疾病 (PAD) 患者數量增加的主要原因，因為患病風險會隨著老齡化的成長而增加。與人口結構變化同步的是，用於診斷、管理和治療周邊動脈疾病 (PAD) 的產品核准激增。這些因素的結合增加了周邊動脈疾病的整體風險，凸顯了與老齡化相關的趨勢、疾病盛行率的增加和醫療保健技術進步之間的複雜交互作用。了解這些動態對於尋求有效解決美國日益加重的周邊動脈疾病負擔的相關人員來說至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 重大投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球周邊動脈疾病市場規模（按類型和複合年成長率）（2025-2032）

• 市場概覽
• 血管成形術用氣球
• 斑塊修飾裝置
• 外周支架
• 周邊導管
• 血流動力學血流調節器
• 下腔靜脈 (IVC) 過濾器
• 周邊設備

全球周邊動脈疾病市場規模（按治療方法和複合年成長率） (2025-2032)

• 市場概覽
• 裝置
  • 支架
  • 氣球
  • 動脈粥狀硬化斑塊切除設備
• 導管
  • 藥物釋放型導管
  • 球囊導管
  • 導管導引線
• 斑塊修飾裝置
• 血流動力學血流調節器
• 其他

全球周邊動脈疾病市場規模（依疾病類型及複合年成長率）（2025-2032）

• 市場概覽
• 降血脂藥物
• 三重H療法
• 血糖值調節劑
• 溶栓藥物
• 心臟正性肌力藥
• 血栓溶解劑
• 抗發炎劑

全球周邊動脈疾病市場規模（依給藥途徑及複合年成長率）（2025-2032）

• 市場概覽
• 口服
• 腸外
• 其他

全球周邊動脈疾病市場規模（依最終用戶和複合年成長率）（2025-2032 年）

• 市場概覽
• 醫院和診所
• 門診外科診所

全球周邊動脈疾病市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Philips（Netherlands）
• Terumo Corporation（Japan）
• Cook Medical（USA）
• Cardinal Health, Inc.（USA）
• B. Braun Melsungen AG（Germany）
• Getinge AB（Sweden）
• Merit Medical Systems, Inc.（USA）
• BIOTRONIK SE & Co. KG（Germany）
• Endologix, Inc.（USA）
• Gore Medical（USA）
• Penumbra, Inc.（USA）
• AngioDynamics, Inc.（USA）
• Johnson & Johnson（USA）
• Bayer AG（Germany）

結論和建議

Peripheral Artery Disease Market size was valued at USD 5.3 billion in 2023 and is poised to grow from USD 5.85 billion in 2024 to USD 12.91 billion by 2032, growing at a CAGR of 10.4% during the forecast period (2025-2032).

As of October 2023, market insights reveal that around 6.5 million Americans aged 40 and older are living with Peripheral Artery Disease (PAD), with heightened susceptibility observed among African Americans. The aging population significantly drives the rise in PAD cases, as risks increase with age. In tandem with this demographic shift, there has been a surge in product approvals aimed at the diagnosis, management, and treatment of PAD. This combination of factors enhances the overall risk of developing PAD, highlighting the complex interplay of age-related trends, increasing disease prevalence, and technological advancements in healthcare. Understanding these dynamics is crucial for stakeholders aiming to address the growing burden of PAD in the United States effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Artery Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Artery Disease Market Segments Analysis

Global Peripheral Artery Disease Market is segmented by Type, Treatment, Disease, Route of Administration, End User and region. Based on Type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava (IVC) Filters and Peripheral Accessories. Based on Treatment, the market is segmented into Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Others. Based on Disease, the market is segmented into Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs,, Inotropes,, Thrombolytic Agents, and Anti-Inflammatory Agents. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Artery Disease Market

The growing prevalence of elderly individuals affected by diabetes and hypertension serves as a critical driver for the peripheral artery disease (PAD) market. Older adults are especially vulnerable to vascular complications, and the presence of these chronic conditions significantly heightens the risk of developing PAD. Diabetes and hypertension contribute to the narrowing and hardening of arterial walls, which in turn restricts blood flow to the limbs, thus increasing the likelihood of PAD. As the number of seniors facing these health challenges continues to rise, the demand for effective PAD treatments and interventions is anticipated to grow, further propelling the market forward.

Restraints in the Peripheral Artery Disease Market

The anticipated recurrence of peripheral artery disease (PAD) following treatment is expected to present a significant barrier to the growth of the peripheral artery disease market in the upcoming years. Despite advancements in medical technology and treatment options, the risk of PAD relapse remains a considerable obstacle to continuous market development. Moreover, concerns related to product recalls within the industry may exacerbate difficulties for the PAD market in the short term. Such recalls can undermine consumer trust, invite increased regulatory scrutiny, and require corrective actions, all of which can hinder overall market growth and stability. Addressing these challenges will necessitate a collaborative approach from stakeholders to effectively manage disease and ensure product safety, thereby supporting the ongoing development of effective therapies for peripheral artery disease.

Market Trends of the Peripheral Artery Disease Market

The Peripheral Artery Disease (PAD) market is poised for significant growth, driven by the increasing prevalence of the disease and a surge in product approvals by regulatory bodies. As PAD, characterized by the narrowing of arteries that supply blood to the limbs, continues to affect a larger segment of the population, the demand for advanced diagnostic and therapeutic solutions becomes paramount. Recent advancements in medical technologies yield innovative treatments and management strategies, directly addressing the complexities of PAD. This favorable landscape indicates a robust market expansion, creating substantial opportunities for stakeholders in the healthcare sector over the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Peripheral Artery Disease Market Size by Type & CAGR (2025-2032)

• Market Overview
• Peripheral Angioplasty Balloons
• Plaque Modification Devices
• Peripheral Stents
• Peripheral Catheters
• Hemodynamic Flow Alteration Devices
• Inferior Vena Cava (IVC) Filters
• Peripheral Accessories

Global Peripheral Artery Disease Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Device
  • Stents
  • Balloons
  • Atherectomy Devices
• Catheters
  • Drug-Eluting Catheters
  • Balloon Catheters
  • Guidewires
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Others

Global Peripheral Artery Disease Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Lipid Lowering Drugs
• Triple-H Therapy
• Glucose Regulating Drugs
• Blood Clot Preventing Drugs,
• Inotropes,
• Thrombolytic Agents,
• Anti-Inflammatory Agents

Global Peripheral Artery Disease Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Parenteral
• Others

Global Peripheral Artery Disease Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Clinics

Global Peripheral Artery Disease Market Size & CAGR (2025-2032)

• North America (Type, Treatment, Disease, Route of Administration, End User)
  • US
  • Canada
• Europe (Type, Treatment, Disease, Route of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Disease, Route of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Disease, Route of Administration, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Disease, Route of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations